Neonatal PDA Treatment Candidacy Estimator

Score clinical and echo features for PDA intervention decisions

Ad placeholder (leaderboard)

Deciding whether and how to treat a patent ductus arteriosus in a preterm infant is one of the more contested judgements in neonatology. This estimator gathers the features clinicians routinely weigh into one structured view to support that discussion.

How it works

The tool assigns points across recognised markers of a haemodynamically significant duct and respiratory burden, then maps the total to a management tier:

ductal diameter >= 2.0 mm        +3
LA:Ao ratio >= 1.8               +3
high-frequency ventilation       +3
gestational age < 26 weeks       +3
... lesser thresholds            +1 / +2 each

score <= 3   -> conservative
score 4-7    -> pharmacological closure
score >= 8   -> surgical / device referral

Two overrides then apply. If the infant is more than three weeks old, the pharmacological window has largely closed and the suggestion shifts to surgical referral. If you flag an NSAID contraindication such as renal failure, thrombocytopenia, necrotising enterocolitis or active bleeding, a pharmacological candidate is likewise moved to surgical referral because drug closure is unsafe.

Important notes

This is deliberately a feature aggregator, not a validated score. The evidence base has moved strongly toward conservative management in recent years, and many significant ducts close spontaneously without intervention. Treat the output as a prompt for the right conversation, never as an instruction. Choice between indomethacin, ibuprofen, paracetamol, surgical ligation and transcatheter device closure depends on local expertise, the infant’s full clinical trajectory and joint neonatal-cardiology assessment.

Ad placeholder (rectangle)